To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
Researchers at the University of Chicago have developed a "universal" chimeric antigen receptor (CAR) platform that offers enhanced safety, adaptability, and the potential to overcome long-standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback